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Nonresponders Responders P
mean+ S.D. mean& S.D.
Improvedin FU 25% 53”/4 0.1892
NYHA 2.47& 0.64 1.79+0.81 0.0065
LVEDDI(cm/m2) 4.12+ 0.53 3.76k 0.53 0.0481
RVASF(%) 29.46+ 11.44 46.56+ 16.31 0.0039
LVEDDI:LVenddiaatolicdiamaterindex;RVASF:rightventricleareaashorteningfraction.
Cono/usion: pts. with lees severe heart failure responded to DBT more
frequently not only in eystolic, but also in diaatolic function. These pte. may
have a better outcome in tailored medioel treatment. Further investigations
are naeded to clarify the role of a pesitive reeponseto DBT teat as favorable
predictive faotor.
m102585 Differential Effects of Exercise end DobutamineStress on Regionsl and Global Left Ventricular
Shape
E. Aveiar, M. Araenault, A.K. Costas, N. Maaani, N. Pandian. Tufts-New
England Medical Centec Boston, Massachusetts, USA
The uee of streeeors to provoke abnormal LV function in patients with is-
chemic heatt diaeaae is well established. We have previously shown that
iachemia produces alterstiona in global and regional LV geometry which can
be quantified ueing Fourier Power Index (Pi) and regional curvature analyeie
(C) and may be of psthophyeiological importance. To determine whether the
effects of different etreaaoreon LV shape we atudied 40 norrrial subjects, 20
with exerciee streas echo (Ex) and 20 who had dobutamine echo (Deb), who
achieved target heart rates without evidence of ischemia. End-diaetolic and
end-ayetolic LV endocerdial contoura in apical long axis and two chamber
viewe at baaeline and peak stress were digitized and analyzed. Results:
(mean + SE): There were no differences in C or PI between groups at
baaeline. Global shape at peak etress: Fourier analyeia of 2 chamber views
revealed a more elongated shape in diaetole and systole with dobutsmine
infusion compared to peak exerciae (diaatolic PI Deb: 27 + 2 vs Ex 19 + 2
and, eyatolic PI Deb: 51 + 4 vs 40 ~ 2; both p < 0.05). In tha long axis, PI
ahowed more elongation with dobutamine than exercise during eyetole(Deb:
49 + 5 va Ex: 35 & 2) but no differences in diaetole. Curvature analysis at
peak etress revealed reduoed curvature of the infariorwall at end-eyetoleonly
with dobutamine (Deb 0.6 + 0.4 vs Ex: 2 + 0.4 p < 0.05). Conclusions: The
phyaiologicel effaeteof exercise and dobutemine atress have distinct effects
on regional and global LV ehape in normal individuals, probab!y related to
the difference in inotropy, preload and afterload.
~025-86) PrognoeticVehre ofaNagativeStress
Echocerdiogram for Cardiec Events in Patients
Undergoing Renel or Liver Trsnsplsntation
P.J.Colon, Ill, B.J. Coplay, F.G. Regenatein, J. Cheirif. Ochsner Medios/
Institutions, New Orleans, LA, USA
Signifiearrt reeourcee are devoted to the oars of patients (pte) undergoing
noneardiac whole organ transplantation. Choosing the optimal modality for
csrdiovaacular riekstratification remains controversial. We hypothesizedthat
a negative etreasechcoardiogram (etreaa2D) could identify ptawhooculd un-
dergo aurgery without further cardiovascular evaluation. We retrospectively
reviewed the oeeee of 79 pts who had a negative stress 2D and underwent
either renal (n = 48, with or without pancreas) or liver (n = 31) transplan-
tation for the occurrence of perioperative cardiac events (cardiac death or
myooarcfialinfarction). Results: The mean age was 49 + 11 years with an
average of 2.3 + 1.2 cardiac risk factors (n = 24 with diabetes mellitus; n
= 59 with hypertension; n = 2 with known coronary artery dieease). Stress
2-D wea performed with exercise in 51% and with dobutamine + atropine in
49%. Target heart rate wee achieved in only 40Y0of the patients with 23Y0
taking beta blocker therapy. No complications occurred as a reeult of stress
2D in any patient. Mean follow-up for the group was 13.6+ 8.9 monthe from
transplantation. Myceerdial infarction occurred on post-op day #2 in one pt
who remaina alive at 25 montha. Additionally, 6 pts experienced noncardiac
deaths dua to post-operative complication (n = 5 sepsia/acidoeis; n = 1
eneephalopathy). Conclusions: 1)Strese 2D can be performed safely in pts
undergoing evaluation for renal or liver tranepiantation; 2) A negative stress
2D ie aeacciated with an excellent prognosis and thus identifies pts who
may safely undergo traneplantation without need for further cardiovascular
evaluation.
11025-87IPro9nosticlmpactof Pharmacological Streee
Testing: Head to Head Comparison between
Echocardiography and Myocardial Perfusion
Scintigrephy
T. Foreter,A. Varga, J. Mester, 0, Fazekae, M. L&ar, M. Csamvidy,
L. Caemay, E. Piceno, A. Szent-Gy6rgyi. University Madical School,
Szeged, Hungary CNR, Institute of C/inica/Phyaio/ogy Pisa, /ta/y
Pharmacological atresstesting with either echocerdiogrsphy ornucieerimeg-
ing techniques gained increasing attention in the pact daeade. The aim of our
study was to compare, head to head, the prognostic power of pharmacolcgi-
oei etresa eohocardiography and perfusion acintigraphy. Three-hundred and
fifty-five patients (age range 20-82 years) underwent pharmacological streas
teating monitored simultaneously with both eehocarcfiogrephyand eeeteMIBl
SPECT perfuaion acintigraphy. The test waa performed using dipyridamole
(up to 0.64 m~kg) in 102 and dobutemine (upto40 @kg/rein and atropine 1
m9) in 253 patients. Criteria of Positivity were new or worsening wail motion
abnormality for echocardiography and a tranaient reversible perfueion defeof
for scintigraphy.The mean duration of the follow-up was 17 monthe. Cardiac
death, non-fatal myooerdial infarction and revaecularization (PTCAor CABG)
were considered as end-points. There were 5 cardiac deaths, 3 infarctions
and 57 revascularization procedure in the follow-up period. The positive
predictive value of echocardiography and perfueion scintigraphy was 40%
and 32%, respaetivaly. The negative predictive value of echocardiogrephy
(90%) wae also aimilar m that of perfusion scintigraphy (92%).
Cone/usiorr.’Pharmacological stress cardiac imaging with either eoho-
cssrdicgrephyor perfusion scintigraphy have comparable prognostic yield in
patients with euepacted or known coronaty artery diaeaae.
11025-881 An Optimal Method for Calculating hlitral Valve
Ares in Patients With Mitral Stenosis by the Flow
Convergence Method: In Vitro Study end Clinical
Validation
S. Nozaki, A.N. DeMaria, M. Yuba, K. Miztishige, H. Morita, H. Matsuo.
Kagawa Medical University Kagawa, Japan, University of Ca/ifomia at San
Diego, San Diago, CA, USA
The aim of this etudy was to determine the most euitable alieaing veloc-
ify/distanoe combination forapplyirrg the hemispheric flow convergence (FC)
method forcslculating mitral valve area (MVA) in patienta with mkral atenoaia.
in vitro study, the maximal flow rate (Q [m!fs]) wee calculated using the hemi-
ephenc FC equation Q = 2Jr* R* * AV * (@/180),where R (cm) is the maximal
rediua of the FC region, AV is the aiiaaing velocity, and .$/180 is a factor ac-
counting forthe inflow angle (1#1).A total of nine different flowe were generated
in an in vitro model with a aharp edged circular orifices of 0.3-1.0 cmz. We.
uaad both planar and funnel ehapad inlet to examine the effect of boundary
geometry. MVA (cm2) wae calculated according to the continuity equation
MVA = Q/V, where V (cf?Vs)ia the peak orifice velooity by the continuoue-
wave Doppler. In 14 patients with typical rheumaticmitralatenoaisaelacted
forimagequalityauitableforquantification,we measuredMVAbyplanimetry
ueingtwo dimensionalechocardiography.The instrument(EUB-185A) waa
capable of alteringAV in 1.0 crrdsincrementsby poet prooesaing.Both in
vitroandclinicaletudy,MVAwae progressivelyundereatimatadwithincreea-
ing AV and decreasingR. Althoughthe centerlinevelocity/dietanoeprofile
was differentbetween planar and funnel inlet, the most suitable AV existed
which reaulta in a R of 1.0 cm. The beet fit was obtained in vitro if MVA
is corrected by contraction coefficient (0.84). MVA estimated by FC methai
at an R of 1.0 cm showed a gwd agreement with MVA by planimetry in
patiente with mitral stenosie (r = 0.96, SEE = 0.22 cmz). This study indicated
an optimal method for the accurate estimation of mitral valve area ueing the
flow convergence method in patients with mitrai stenosis.
11025-891EchCosrdiOgrsphyHas Reduced the~eedOf
Csrdiac Cstheterization in Patiants With Aortic
Stenosis Prior to Aortic Valve Surgery
A.D. Popovic, A.N. Ne5kovic, M.S. Lauer, D.M. Cosgrove, ill,
W.J. Stewari 1,J.D. Thomaa. Dedinje Cardiovascular Institute, Belgrade
University Medical School, Belgrade, Yugoslavia, 1Cardiovascular hrraging
Centec Departments of Cardiobgy arrd Cardiothoracic Surgery The
Cleveland Clinic Foundation, Cleveland, OH, USA
In order to assess the likelihood of cardiac catheterization in pts with aortic
stenosis undergoing aoriic valve surgery, we have analyzed 2789 surgical
procedure at the Cieveland Ciinic from 1966 to 1994. Statistical analysis
was pefiornred using multiple logistic regression model with preoperative
cardiac catheterization as a dependent variable and patient age and sex,
date of surgery, type of surgery (valve surgery with or without CABG), and
